L-Carnitine hydrochloride

Research use only, not for human use.

It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.

Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. (In Vitro):When expressed in human embryonic kidney (HEK)293 cells, hOCTN2 (SLC22A5) shows low but significant stereospecific transport activity: D-carnitine is transported with lower affinity (Km=10.9 μM) than the L-isomer (Km=4.3 μM).

When expressed in human embryonic kidney (HEK)293 cells, hOCTN2 (SLC22A5) shows low but significant stereospecific transport activity: D-carnitine is transported with lower affinity (Km=10.9 μM) than the L-isomer (Km=4.3 μM).

——

——

Others

Other Targets

CRAT

Other Indications

——

10017-44-4

197.66

C7H15NO3·HCl

>98% (HPLC)

DMSO: > 10 mM

C[N+](C)(C)C[C@H](CC(=O)O)O.[Cl-]

——

(-20℃)

With Ice Pack

≥ 2 years